Study shows KRIs improve data quality when used as part of a holistic RBQM plan
Authors: Steve Young, Chief Scientific Officer Sylviane de Viron, Data and Knowledge Manager In the face of ever-increasing clinical trial complexity, costs, and timelines, centralized
RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies
King of Prussia, PA – 6 February 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, have announced a significant milestone
CluePoints Appoints Andy Cooper as New Chief Executive Officer
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper has been appointed as its new Chief Executive Officer. Cooper succeeds
RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints, is marking its tenth anniversary this year – placing it at the
Federated Learning & Risk-Based Data Management – The Future of Smart Healthcare
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the application of machine learning (ML) in healthcare and clinical research.”
CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities
King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award
CluePoints Continues Impressive Global Growth with Three New Senior Appointments
King of Prussia, PA – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing
UK Regulator Cites CluePoints’ Solutions in Updated Guidance
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated
CluePoints Senior Vice President, Europe, and APAC, to Speak at SCOPE 2022
John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful decentralized trials at this year’s SCOPE Conference, a Summit for
HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China
King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has collaborated with CluePoints, the premier provider of Risk-Based Study Execution (RBx)